Gain detailed insights into the trading activity of Congress members for NOV on our government trades page. Stay updated on how elected officials are investing in NOV.

NOV - Government Trades

NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.

handshake merger

Equities

News

Arcosa Inc seals $180 million deal to acquire Ameron Pole Products from NOV Inc. Ameron, founded in 1970, specializes in premium concrete and steel poles for various infrastructure applications. Acquisition expands Arcosa&#39;s market presence with four strategically located manufacturing facilities. 

Arcosa Illuminates Its Portfolio with $180M Ameron Pole Products Acquisition

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ADXN

AEON

AGFY

ALRN

Adtalem Global Education Inc. Common Stock

ATGE

ATPC

BCLI

BORR

CALX

CISS

CNSP

CVLT

IFBD

IMCC

KURA

MBIN

MBUU

MOTS

NVVE

NYAX

NYXH

ONMD

PALI

PRTA

PTPI

PXLW

REVB

RVSN

SANM

SIDU

SLNA

SWIN

SXTP

TIVC

WFRD

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales 

Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Short Ideas

Pre-Market Outlook

AESI

The most overbought stocks in the energy sector presents an opportunity to go short on these overvalued companies.

Top 5 Energy Stocks That Should Keep You Up At Night

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Earnings

Macro Economic Events

Economics

AAPL

COIN

IBKR

JBHT

MSFT

NVDA

PNFP

SCHW

Economists expect this morning’s retail sales data to show the strongest growth since January. If a recession is coming, somebody forgot to tell the consumer!

What The Nasdaq-100 Will Look Like After July 24

Price Target

Analyst Ratings

ACAD

OUST

SBUX

SPOT


	Keybanc boosted the price target for  Spotify Technology S.A. (NYSE: SPOT) from $180 to $205. Keybanc analyst Justin Patterson maintained an Overweight rating. Spotify shares rose 0.9% to $172.68 in pre-market trading.


Microsoft To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Friday

General

$BTC

$ETH

ALLY

AMZN

ATVI

BABA

BIDU

COHR

DOCS

FIRST REPUBLIC BK CA by First Republic Bank (San Francisco, California)

FRCB

HBAN

KEYS

LILA

MNDY

NYCB

ONON

PACW

PARA

QRTEP

SKYW

Institutional investors have been dumping stocks for the last 12 months. You have to ask yourself some serious questions when you see this.

Burry In Q1: &#34;Sell&#34;, Also Burry In Q1:

HAYW

INTU

MDWD

NTRS


	UBS cut  Microsoft Corporation  (NASDAQ: MSFT) price  target from $300 to $250. UBS analyst Karl Keirstead downgraded the stock from Buy to Neutral. Microsoft shares fell 2% to $234.73 in pre-market trading.


Starbucks To Rally 11%? Here Are 10 Other Analyst Forecasts For Wednesday

FICO

GRTS

 
	Barclays slashed the price target on  Block, Inc.  (NYSE: SQ) from $130 to $100. Block shares rose 1% to $60.70 in pre-market trading.
	


Block To 100? Plus This Analyst Slashes PT On Estée Lauder By 32%

Long Ideas

Mid Cap

Emerging Markets

Upgrades

Commodities

Management

Bank Of America analyst Chase Mulvehill upgraded NOV (NYSE: NOV) with a price target of $19.

Key Takeaways: &#34;Trickle-down on the move; upgrade to Buy,&#34; Mulvehill said in a note. 

Is 2023 The &#39;Trickle-Down Year&#39; For NOV? Why This Wall Street Analyst Is Bullish

AMTD

AXTI

CROX

DECK

FIVN

FSLR

GETY

GTLS

HAYN

LTRPB

MITK

SLCA

SRPT

TECK

APPL

U.S. stocks closed higher on Friday, with the Dow Jones jumping more than 300 points. Here is the list of some big stocks moving higher in the previous session.

Chevron, Amazon And Some Other Big Gainers From Friday

NOV Inc

Sunnova Energy International Inc. Common Stock

Sunnova Energy International Inc

Novation Companies Inc

NVN Liquidation Inc

SHL Telemedicine Ltd PGIM US Large-Cap Buffer 12 ETF - November

Nova Royalty Corp Ordinary Shares

Novusterra Inc

Novanta Inc

Nova Vision Acquisition Corp. - Ordinary share

Nova Vision Acquisition Corp

Nova Vision Acquisition Corp. - Rights

TrueShares Structured Outcome (November) ETF

<h3>Gainers</h3>
<ul>
<li><strong>Tetra Technologies</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTI#NYSE">TTI</a>) stock rose 4.9% to $3.63 during Tuesday's after-market session. The market value of their outstanding shares is at $476.0 million. </li>
<li><strong>TXO Partners</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXO#NYSE">TXO</a>) shares increased by 4.84% to $21.02. The company's market cap stands at $650.3 million. </li>
<li><strong>Comstock</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LODE#AMEX">LODE</a>) stock rose 4.53% to $0.23. The market value of their outstanding shares is at $32.4 million. </li>
<li><strong>Enservco</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ENSV#AMEX">ENSV</a>) stock moved upwards by 3.94% to $0.26. The company's market cap stands at $7.0 million. </li>
<li><strong>Enviva</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVA#NYSE">EVA</a>) stock rose 3.31% to $0.58. The company's market cap stands at $43.1 million. </li>
<li><strong>FutureFuel</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FF#NYSE">FF</a>) shares rose 2.06% to $4.45. The market value of their outstanding shares is at $194.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Atlas Energy Solutions</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AESI#NYSE">AESI</a>) shares decreased by 2.7% to $21.4 during Tuesday's after-market session. The company's market cap stands at $2.3 billion. </li>
<li><strong>Tellurian</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TELL#AMEX">TELL</a>) shares decreased by 1.97% to $0.56. The market value of their outstanding shares is at $471.3 million. </li>
<li><strong>Noble Corp</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NE#NYSE">NE</a>) shares fell 0.82% to $42.55. The market value of their outstanding shares is at $6.0 billion. </li>
<li><strong>Houston American Energy</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/HUSA#AMEX">HUSA</a>) stock declined by 0.76% to $1.31. The market value of their outstanding shares is at $14.2 million. </li>
<li><strong>Crescent Energy</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRGY#NYSE">CRGY</a>) shares decreased by 0.75% to $12.37. The company's market cap stands at $1.3 billion. </li>
<li><strong>NOV</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) stock decreased by 0.35% to $17.22. The company's market cap stands at $6.8 billion.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-energy-stocks/" title="www.benzinga.com/money/best-energy-stocks/">www.benzinga.com/money/best-energy-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CRGY

ENSV

HUSA

LODE

TELL

12 Energy Stocks Moving In Tuesday's After-Market Session

WIIM

CIVI

CLNE

FANG

LBRT

MTDR

NCSM

PNRG

PTEN

TALO

Shares of several oil & gas companies are trading lower following an OPEC+ meeting in which members said they would start phasing out voluntary production cuts in October.

AROC

EURN

TRGP

VIST

Shares of oil and gas stocks are trading lower amid a drop in the price in crude.

<p>The dividend is payable on June 28, 2024 to each stockholder of record on June 14, 2024.</p>


Dividends

NOV Boosts Regular Quarterly Dividend By 50% From $0.05 To $0.075 Per Share

<p>NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $24.83, a high estimate of $26.00, and a low estimate of $22.00. This current average has decreased by 8.04% from the previous average price target of $27.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714410084_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>The standing of NOV among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Marc Bianchi</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$26.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Charles Minervino</td>
<td>Susquehanna</td>
<td>Maintains</td>
<td>Positive</td>
<td>$26.00</td>
<td>-</td>
</tr>
<tr>
<td>Luke Lemoine</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Keith Mackey</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$24.00</td>
<td>-</td>
</tr>
<tr>
<td>Stephen Gengaro</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$26.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>James Rollyson</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to NOV. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of NOV compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of NOV's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of NOV's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/NOV/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on NOV analyst ratings.</strong></a></p>
<h2>All You Need to Know About NOV</h2>
<p>NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing more than 60% of its annual revenue.</p>
<h3>Key Indicators: NOV's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> NOV displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately <strong>13.02%</strong>. This indicates a notable increase in the company's top-line earnings. When compared to others in the Energy sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> NOV's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>25.52%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> NOV's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>10.23%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>5.49%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> NOV's debt-to-equity ratio is below the industry average. With a ratio of <b>0.39</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Breaking Down NOV: 6 Analysts Share Their Views

<p>TD Cowen  analyst Marc Bianchi   maintains NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Buy and lowers the price target from $27 to $26.</p>


TD Cowen Maintains Buy on NOV, Lowers Price Target to $26

<p>NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.27 by 11.11 percent. This is a 6.25 percent decrease over earnings of $0.32 per share from the same period last year.  The company reported quarterly sales of $2.15 billion which beat the analyst consensus estimate of $2.11 billion by 2.13 percent.  This is a 9.84 percent increase over sales of $1.96 billion the same period last year.</p>


NOV Q1 EPS $0.30 Beats $0.27 Estimate, Sales $2.15B Beat $2.11B Estimate

<p>Ratings for NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated NOV and provided 12-month price targets. The average target is $24.6, accompanied by a high estimate of $26.00 and a low estimate of $22.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 8.89%. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1712592022_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The perception of NOV by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Charles Minervino</td>
<td>Susquehanna</td>
<td>Maintains</td>
<td>Positive</td>
<td>$26.00</td>
<td>-</td>
</tr>
<tr>
<td>Luke Lemoine</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Keith Mackey</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$24.00</td>
<td>-</td>
</tr>
<tr>
<td>Stephen Gengaro</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$26.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>James Rollyson</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to NOV. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of NOV compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for NOV's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Capture valuable insights into NOV's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/NOV/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on NOV analyst ratings.</strong></a></p>
<h2>Delving into NOV's Background</h2>
<p>NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing more than 60% of its annual revenue.</p>
<h3>Key Indicators: NOV's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> NOV displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately <strong>13.02%</strong>. This indicates a notable increase in the company's top-line earnings. When compared to others in the Energy sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> NOV's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>25.52%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> NOV's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>10.23%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> NOV's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>5.49%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.39</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Expert Ratings For NOV

<p>Susquehanna  analyst Charles Minervino   maintains NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Positive and maintains $26 price target.</p>


Susquehanna Maintains Positive on NOV, Maintains $26 Price Target

<p><strong>Arcosa Inc&nbsp;</strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACA#NYSE">ACA</a>) has entered into a definitive agreement to acquire&nbsp;<strong>Ameron Pole Products, LLC</strong>&nbsp;from&nbsp;<strong>NOV Inc&nbsp;</strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>)&nbsp;<a target="_blank" href="https://www.benzinga.com//node/37582281" rel="noreferrer noopener">for $180 million in cash.</a></p>
<p>Founded in 1970, Ameron is a manufacturer of engineered, premium concrete and steel poles for a broad range of infrastructure applications, including lighting, traffic, electric distribution, and small-cell telecom.</p>
<p>Ameron has four manufacturing facilities strategically located in Alabama, California, and Oklahoma.</p>
<p>For the year ended December 31, 2023, Ameron posted $94 million in revenues and Adjusted EBITDA of approximately $20 million.</p>
<p>Arcosa will fund the $180 million purchase price with a combination of cash on hand and borrowings available under its revolving credit facility.</p>
<p>&#8220;It provides entry into the complementary steel and concrete lighting pole market while expanding our product offerings in traffic and telecom,&#8221; said Arcosa&#8217;s President and CEO Antonio Carrillo.</p>
<p>The company held $104.8 million in&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/02/b37271896/arcosa-inc-announces-fourth-quarter-and-full-year-2023-results" rel="noreferrer noopener">cash and equivalents as of December 31, 2023</a>.</p>
<p>The company expects to close the transaction in the second quarter of 2024.</p>
<p><strong>Price Action</strong>: ACA shares are trading lower by 1.02% at $83.86 on the last check Monday.</p>
<p><em>Photo via Shutterstock</em></p>


<ul>
<li>Acquisition Provides Additional Scale to Engineered Structures in Attractive Infrastructure Markets and is Accretive to Overall Arcosa Margin</li>
<li>Marks Entry into Complementary Concrete and Steel Pole Lighting Market</li>
<li>Expands Position in Traffic and Telecommunication Structures</li>
<li>$180 Million Purchase Price to be Funded with Cash and Available Revolver Capacity</li>
</ul>
<p>Arcosa, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACA#NYSE">ACA</a>) ("Arcosa," the "Company," "We," or "Our,"), a provider of infrastructure-related products and solutions, today announced that it has entered into a definitive agreement to acquire Ameron Pole Products, LLC ("Ameron") from NOV Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) for $180 million in cash.</p>
<p>Founded in 1970, Ameron is a leading manufacturer of highly engineered, premium concrete and steel poles for a broad range of infrastructure applications, including lighting, traffic, electric distribution, and small-cell telecom. With four manufacturing facilities strategically located in Alabama, California, and Oklahoma, Ameron serves its customers with a nationwide presence. For the year ended December 31, 2023, Ameron had revenues of approximately $94 million and Adjusted EBITDA of approximately $20 million, implying a 9.0x EBITDA acquisition multiple.</p>
<p>Commenting on the transaction, Antonio Carrillo, Arcosa's President and Chief Executive Officer, noted, "As we continue to effectively deploy capital into Arcosa's growth businesses, we believe Ameron is an excellent strategic fit. It provides entry into the complementary steel and concrete lighting pole market while expanding our product offerings in traffic and telecom. The acquisition bolsters our Engineered Structures segment and increases our exposure to growing infrastructure end markets at an attractive valuation. We look forward to welcoming the Ameron team to Arcosa and combining our strengths to accelerate growth."</p>
<p>The Company expects to fund the $180 million purchase price with a combination of cash on-hand and borrowings available under its revolving credit facility. The transaction, which has been approved by the Company's Board of Directors, is subject to customary closing conditions and regulatory provisions under the Hart-Scott-Rodino Act and is expected to close in the second quarter of 2024.</p>
<p>For supplemental information on the transaction, please refer to materials located on our website at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.arcosa.com%2Fnews-events%2Fevents-presentations%2Fdefault.aspx&amp;esheet=53907431&amp;newsitemid=20240311388934&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.arcosa.com%2Fnews-events%2Fevents-presentations&amp;index=1&amp;md5=211ab66c9e0c387f6cd885c852fbfa04">https://ir.arcosa.com/news-events/events-presentations</a>.</p>
<p><strong>Non-GAAP Financial Measures</strong></p>
<p>This press release contains financial measures that have not been prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). Reconciliations of non-GAAP financial measures to the closest GAAP measure are included in the accompanying table to this release.</p>


Arcosa Announces Agreement To Acquire Ameron Pole Products From NOV Inc. For $180M In Cash

<p>Piper Sandler has decided to maintain its Neutral rating of NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) and lower its price target from $25.00 to $22.00.</p>
<p>Shares of NOV are trading down 0.75% over the last 24 hours, at $17.09 per share.</p>
<p>A move to $22.00 would account for a 28.73% increase from the current share price.</p>
<h3>About NOV</h3>
<p>NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing more than 60% of its annual revenue.</p>
<h3>About Analyst Ratings</h3>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Piper Sandler Maintains Neutral Rating for NOV: Here's What You Need To Know

<p>5 analysts have expressed a variety of opinions on NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $25.8, a high estimate of $29.00, and a low estimate of $24.00. A decline of 7.86% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1707235221_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The standing of NOV among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Keith Mackey</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$24.00</td>
<td>-</td>
</tr>
<tr>
<td>Stephen Gengaro</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$26.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>James Rollyson</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Marc Bianchi</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Outperform</td>
<td>$29.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Announces</td>
<td>Overweight</td>
<td>$25.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to NOV. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of NOV compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of NOV's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into NOV's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/NOV/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on NOV analyst ratings.</strong></a></p>
<h2>About NOV</h2>
<p>NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing more than 60% of its annual revenue.</p>
<h3>NOV's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, NOV showcased positive performance, achieving a revenue growth rate of <strong>7.23%</strong> as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.</p>
<p><strong>Net Margin:</strong> NOV's net margin excels beyond industry benchmarks, reaching <strong>25.52%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> NOV's ROE excels beyond industry benchmarks, reaching <strong>10.17%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> NOV's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>5.49%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.38</strong>, NOV adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


In-Depth Examination Of 5 Analyst Recommendations For NOV

<p>RBC Capital  analyst Keith Mackey   reiterates NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Sector Perform and maintains $24 price target.</p>


Reiteration

RBC Capital Reiterates Sector Perform on NOV, Maintains $24 Price Target

<p>Stifel  analyst Stephen Gengaro   maintains NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Buy and lowers the price target from $28 to $26.</p>


Stifel Maintains Buy on NOV, Lowers Price Target to $26-Report Released on  4 February 2024

<p>Raymond James  analyst James Rollyson   maintains NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) with a Outperform and lowers the price target from $28 to $25.</p>


Raymond James Maintains Outperform on NOV, Lowers Price Target to $25


Daniel GoldmanHouse (D-NY)	$1K - $15K	Sale	May 19, 2023	Apr 10, 2023	House
Daniel GoldmanHouse (D-NY)	$1K - $15K	Purchase	Apr 17, 2023	Mar 01, 2023	House

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Government Trades

NOV Inc

top performing NOV trades